Jonathan Mcneill serves as Executive at Dyne Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan Mcneill has executed 52 insider transactions totaling $5.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 20, 2021 involved selling 545 shares valued at $8.5K.
Jonathan Mcneill currently holds 159,707 shares of Dyne Therapeutics, Inc. (DYN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Mcneill has been a net seller of DYN stock. They have purchased $0 and sold $5.6M worth of shares.
Jonathan Mcneill's most recent insider trade was on Sep 20, 2021, when they sold 545 shares at $15.61 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |